This program is funded by an independent grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.
Join our global experts for this accredited CME six part MASH Academy with address from the American Liver Foundation. Our third of six sessions is presented by leading expert Professor Maya Balakrishnan.
Identifying patients at risk of complications from MASH, including cirrhosis and cardiovascular disease
In this focused teaching session, gastroenterologists, hepatologists and other healthcare professionals will learn to identify patients at risk of serious complications from Metabolic Associated SteatoHepatitis (MASH), such as cirrhosis and cardiovascular disease. The session will equip participants with the skills to utilize clinical signs and patient history to recognize early indicators of disease progression effectively. It will guide professionals on how to formulate a comprehensive care plan, integrating appropriate referral pathways for advanced care and specialist consultations. This comprehensive approach ensures that high-risk patients receive timely and coordinated treatment, enhancing outcomes and mitigating the risk of severe complications.
Who is this course for
This online education program has been designed solely for healthcare professionals in the USA. The course provides continuing education for:
✅ Gastroenterologists
✅ Hepatologists
✅ Primary Care Physicians
✅ Endocrinologists
✅ Cardiologists
✅ Nurse Practitioners
✅ Physician Assistants
✅ Dietitians/Nutritionists
✅ Pharmacists
✅ Other Health Professionals
Faculty
Professor Maya Balakrishnan
Dr. Maya Balakrishnan is an Assistant Professor of Medicine in Gastroenterology at Baylor College of Medicine and a physician at Ben Taub General Hospital. With interests in liver and gastrointestinal diseases, Dr. Balakrishnan combines her public health expertise to study chronic liver disease risk factors and develop interventions. She established the NAFLD program at Ben Taub and leads multiple clinical trials. She focuses on reducing health inequities, particularly in liver diseases affecting vulnerable groups.Dr. Balakrishnan holds an MD from Harvard and an MPH from Harvard School of Public Health, and she completed her training at Yale.
Continuing Education Information
This continuing education activity is provided by AffinityCE and MedAll. This activity provides continuing education credit for physicians, physician assistants, nurses, and nurse practitioners and pharmacists. A statement of participation is available to other attendees.
Faculty, planners, and staff disclosure information
Maya Balakrishnan has received Research contracts from Madrigal Pharmaceuticals, Intercept Pharmaceuticals, Viking Theraputics & Novo Nordisk. Tony Villiotti has consulted for Madrigal Pharmaceuticals & Regeneron. Lorriane Stiehl has no relevant financial relationships with ineligible companies to disclose and no unapproved product related discussions to disclose.
AffinityCE/MedAll staff and the planners and reviewers of this educational activity have no relevant financial or non-financial interests to disclose.
Mitigation of Relevant Financial Relationships
AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.
Activity Accreditation for Health Professions
Physicians This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and Medall. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity for a maximum of 1.5 _AMA PRA Category 1 Credits_™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity for a maximum of 1.5 _AMA PRA Category 1 Credits_™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity for a maximum of 1.5 _AMA PRA Category 1 Credits_™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.
Nurses Continuing Nursing Education is provided for this program through the joint providership between MedAll and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This live activity provides a maximum of 1.5 hours of continuing nursing education credit.
Criteria for Claiming CNE Credit: Participants must have registered and attended the entire program. Attendance is monitored online for participation in the entire activity.
Pharmacists AffinityCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).
UAN: 0829-9999-24-156-L01-P
Activity Type: Knowledge-based
CEUs: 1.5
No cost to participate.
Participant CE records will be electronically communicated to CPE Monitor.
Pharmacist Learning Objectives
At the conclusion of this web conference, participants should be able to:
Identify patients at risk of complications from MASH, including cirrhosis and cardiovascular disease:
- Utilize clinical signs and patient history to recognize early indicators of disease progression.
- Formulate a comprehensive care plan that includes appropriate referral pathways for advanced care and specialist consultation.
Criteria for Claiming CPE Credit: Participants must have registered and attended the entire program. Attendance is monitored online for participation in the entire activity.
System Requirements
Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program
Other Health Care Professionals All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.
Participation Costs
There is no cost to participate in this program.
CME Inquiries
For all CME policy-related inquiries, please contact us at ce@affinityced.com.
How to Earn CE Credit
At the end of the live session participants will be sent an email with a feedback form. On completion of the feedback form participants with be issued a certificate with their CE credit.
How to Earn CE Credit: Pharmacists Only
Diagnostic Updates in Metabolic Dysfunction-Associated Steatohepatitis
Registration for the Activity does not establish an account in the CE Center or automatically provide continuing education credit. You must sign into the CE Center site and evaluate the content of the activity to earn CE credit.
1.Please use the private evaluation link provided to you to access the CE Center.
IMPORTANT: You must use this link every time you access the CE Center for this activity.
2. Select the activity: Identifying Complications in Metabolic Dysfunction-Associated Steatohepatitis
3. Enter an e-mail address and password to begin setting up your profile. Select “I Forgot My Password” if you need to reset the password you set up.
4. Verify, correct, or add your information.
5. Participants claiming Pharmacist CE credits will need to supply their Date of birth and NABP e-Profile ID. Pharmacy CE records will be electronically communicated to CPE Monitor.
6. Complete the post-activity evaluation after attending the entire program.
7. After completing the activity evaluation, you will be able to download your CE certificate. Your CE record will also be stored here for later retrieval.
8. The website is open for completing your evaluation until July 31, 2024.
9. After the website has closed, you can come back to the site at any time to download your certificate, but you will not be able to add any evaluations.Please send any customer service requests to cds_support+medall@affinityced.com.